- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Plaque psoriasis
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1283KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 137KB)
Ustekinumab – March 2021
Ustekinumab: Injection 45 mg in 0.5 mL, Stelara®
Last updated
2 July 2021